| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.2 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 9e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.27 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.6 | 0.02 |